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INTRODUCTION
Active management versus physiological management of the third stage of labour has been debated in the literature since the 1980s (Begley, 1990; Dixon, Fullerton, Begley, Kennedy, & Guilliland, 2011; Jangsten, Mattsson, Lyckestam, Hellstrom, & Berg, 2011; Prendiville, Harding, Elbourne, & Stirrat, 1988; Rogers et al., 1998; Thilaganathan, Cutner, Latimer, & Beard, 1993) . Active management has been identified as consisting of three interventions: prophylactic uterotonic administration, early cord clamping before cord pulsation ceases, and controlled cord traction (Begley, Gyte, Devane, McGuire, & Weeks, 2015) . In physiological management the placenta is delivered spontaneously with the aid of gravity and sometimes by maternal effort without those three interventions (Begley et al., 2015) .
In their Cochrane systematic review aimed at assessing the effectiveness of active or expectant management of the third stage of labour, Begley et al. (2015) found active management of the third stage reduced the risk of a haemorrhage greater than 1000ml. They concluded that active management has benefits for women at mixed levels of risk for bleeding, although "there was an absence of high-quality evidence" (Begley et al., 2015, p.1) , but that adverse effects were also identified. The studies included in the review involved births in hospital only settings with women often experiencing intervention during the first and second stages Background: Debate continues as to whether active or physiological management of the third stage of labour reduces the risk of postpartum haemorrhage for healthy well women. However, little attention has been paid to what volume of blood loss should be considered within normal range when the birth has been physiological, including physiological management of the third stage. At midwife-run maternity homes in Japan, midwives support physiological labour and birth, including the third stage, with protocols in place which govern when to intervene, refer and transfer to hospital obstetric care.
Objectives:
To describe and quantify and gauge the significance of blood loss volume following birth when labour, birth and third stage have been physiological at one Japanese maternity home.
Method:
Retrospective cohort study with data being extracted from the birth records of 512 women who gave birth at a maternity home between January 2007 and February 2010. Blood loss was measured up to two hours postpartum.
Findings:
Among the 512 births, we determined the means of parity as 2.2 (SD=0.86), blood loss up to two hours post-delivery as 608.7ml (SD=403.1), and length of the third stage of labour as 12.9min (SD=7.7). Blood losses of between 0-499ml, 500-999ml, 1000-1499ml, 1500-1999ml and ≥2000ml were 52.3%, 31.6%, 11.3%, 4.1% and 0.6%, respectively. Therapeutic intravenous uterotonics were provided to 3.1% of women when blood loss was <1000ml but given to 83.3% when blood loss exceeded 1500ml. Furthermore, 5.6% of the women received IV iron therapy when blood loss was <1000ml, while all the women did when blood loss exceeded 1500ml. Mean haemoglobin level at four days postpartum with blood loss >1500ml was 8.3 g/dl (SD=1.0) which was significantly lower than the mean of 9.8 g/dl (SD=1.2) calculated for the women who had a blood loss of 1000-1499ml and the 9.6 g/dl mean (SD=0.9) for the women with a blood loss of 500-999ml (F=27.92, p<0.001). Of those reported (n=11), mean haemoglobin levels in all groups increased to almost 11 g/dl after two weeks.
of labour, such as induction and /or augmentation of labour and instrumental delivery (Begley, 1990; Khan, John, Wani, Doherty, & Sibai, 1997; Prendiville et al., 1988; Rogers et al., 1998) .
In contrast, Dixon et al. (2011) conducted a systematic review aimed at assessing outcomes for low risk women who had a physiological labour and birth followed by physiological third stage care. The women included in this review had no interventions (such as induction/augmentation) during labour and birth. Using this definition Dixon et al. (2011) found four studies that met the review criteria. These demonstrated no increased risk of haemorrhage with physiological management and the authors then questioned the use of active management for low risk women. This review included a retrospective study from New Zealand of a cohort of low risk women who had had no interventions during labour and birth and had received physiological third stage care. Their findings indicated an increased risk of blood loss of more than 500ml with active management (Dixon et al., 2009 ).
Research studies to date have compared physiological and active management of the third stage with a focus on which method can reduce the volume of blood loss. With a blood loss volume of more than 500ml classed as a postpartum haemorrhage, the underlying assumption is that lower volumes are optimal for women. Throughout history, excessive blood loss during childbirth, with its resultant morbidity and mortality, has been one of the greatest concerns facing healthcare professionals. Consequently, emphasis has been put on the reduction of excessive blood loss during the third stage, yet little attention has been paid to what should be considered a normal range of blood loss volumes for a normal physiological birth. Gyte (1992) suggested that blood loss at birth is "physiologically normal" and is part of the mechanism which brings the mother's blood volume back to its non-pregnant level. But how much is normal is debatable (Begley et al., 2015) .
Postpartum haemorrhage (PPH) is defined by the World Health Organization (WHO) as a blood loss exceeding 500ml. This definition is problematic (Cunningham & Williams, 2001) because, if measured quantitatively, it transpires that a considerable number of women have a loss exceeding 500ml. In one study, when chromium-labelled red blood cells were used to measure the blood volume lost from the circulation, 39% of women had lost more than 500ml (Pritchard, Wiggins, & Dickey, 1962) . Another study by Brant (1967) used a washing machine extraction method and found that 21.5% of women had lost more than 500ml of blood at delivery. Newton, Mosey, Egli, Gifford, and Hull (1961) used the acid-hematin spectrophotometric method to identify the mean blood loss, of a cohort of primiparas without oxytocin after the delivery of the placenta, and the result was a mean of 613ml.
Visual estimation is the most frequently practised method of judging blood loss during childbirth. Newton et al. (1961) and Brant (1967) compared visually estimated blood loss to measured blood loss and found that there was considerable underestimation, a finding replicated by others. Schorn (2010) reviewed 46 studies which compared actual measurement and estimated blood loss during childbirth, and found that visual estimation is inaccurate. She argues that estimated blood loss should be eliminated from routine assessment and documentation and that a combination of direct measuring and weighing is optimal.
Returning to the challenge of the current WHO definition of PPH, a blood loss of more than 500ml may not necessarily be an abnormal event. Well-nourished, healthy women are able to compensate a blood loss of up to 1000ml (Blackburn, 2008; Cunningham & Williams, 2001; Frye, 2004) . This is because the total blood volume during pregnancy can potentially increase by between 1400ml and 2000ml (Bloomfield & Gordon, 1990; Cunningham & Williams, 2001) . In 1996 WHO refined its definition of PPH stating that blood loss of up to 1000ml could be considered physiological dependent on the woman's response to that loss (WHO, 1996) .
In our study we consider that physiological blood loss during the third stage is the amount of blood that the woman's body sheds as a way of restoring equilibrium within the maternal circulation, during the transition from pregnancy hypervolemia to the nonpregnancy state.
Japanese independent midwives run their own maternity homes without needing a physician to be present. They are required by law to have a contract with a back-up physician and an institution. Only low risk women are supported to give birth in these maternity homes with a normal birth expected. Practice Guidelines for Maternity Homes (Japanese Midwives ' Association, 2005 ' Association, , 2009 ) designate the criteria for whether a woman can have care from a midwife alone, needs co-management with a backup physician, or needs referral to an obstetrician. Well pregnant women, with a singleton fetus and cephalic presentation, are seen by an obstetrician during pregnancy and, if expected to be able to have a spontaneous vaginal birth, can be managed by midwives autonomously (Japanese Midwives ' Association, 2005 ' Association, , 2009 . In these circumstances midwives aim to support normal physiological birth of the baby and the placenta. The midwives take care of women throughout pregnancy, continuously nurturing women physically and mentally, to make physiological birth successful. Women are free of medical interventions and free to choose any position to give birth. No prophylactic uterotonics are used in the third stage, although some emergency medicines, such as uterotonics and intravenous infusions, and medical procedures can be used according to a given protocol with a back-up physician if haemorrhage occurs.
Midwifery-led maternity homes in Japan are unique places for childbirth in that medicine and /or medical procedures are prohibited by law. This study was prompted because the midwives working at one particular maternity home felt, overall, that the total blood loss in the women they provided care for without uterotonics, seemed to exceed what is traditionally defined as a PPH. However, almost all these women have an uneventful postpartum period.
Physiological labour, birth and third stage are more likely to occur in maternity homes, so exploring care provision and outcomes in this setting is likely to provide more understanding of what could be considered normal blood loss following physiological birth. Therefore, the aim of this study was to describe, quantify and gauge the significance of blood loss volume over a set time period, following birth when labour, birth and the third stage have been physiological within one midwifery-led maternity home in Japan.
STUDY SETTING
The maternity home in this study provides care for low risk women up to one month postpartum. This maternity home has about 150 births a year on average and six to seven midwives provide care to all women, rostering shifts to cover each 24 hours. The midwives share information about women closely and all the midwives get to know all the women, resulting in individualised and continuity of care from pregnancy through to the postpartum period.
All midwives are aware that they cannot give medicines within the maternity home and all are confident in managing a physiological third stage, including how and when to identify excessive blood loss. Health promotion and non-pharmaceutical care takes place throughout the antenatal period to help make physiological birth, including the third stage, possible.
The placenta is delivered spontaneously without either the administration of a prophylactic uterotonic agent or fundal massage or suprapubic pressure. After the baby is born and has been placed onto the mother's chest for skin to skin time, the umbilical cord is clamped and cut after making sure pulsation has ceased. Most women lie supine for the delivery of the placenta and are sometimes encouraged to push or squat.
In Japan, blood loss at birth is defined as the volume of blood lost within two hours of the birth, with haemorrhage being defined as a loss of more than 500ml (Japan Society of Obstetrics & Gynecology, 2003) . According to this definition, blood loss is measured at the end of the third stage, and then one hour and two hours later.
In our maternity home, when giving birth, the women are on three layers of collection sheets. The top layer is for amniotic fluid and is removed as soon as the baby is placed onto the mother's chest so that amniotic fluid is not mixed with blood loss. Then the placenta is delivered onto a second sheet which also collects the blood loss. Any extensive blood loss is collected on the third sheet, which is also weighed while the placenta is inspected. Any additional coagulated blood on the surface of the placenta is removed and placed onto the third sheet. Then all sheets are removed and weighed. The collection sheets are weighed before and after use. All gauzes and pads are also weighed before and after use. This constitutes the data collection at the end of third stage. Then a new pad is applied and then weighed after one hour, before being replaced with a second new pad which is weighed at the conclusion of the second hour. Total blood loss is then calculated to assess whether or not it was a haemorrhage. This method has been routine practice at this maternity home and was introduced to ensure consistency of measurement. The midwives felt it was important to measure blood loss accurately to facilitate their decision-making process regarding the care they provided. In addition, the maternity home was a place of teaching, where consistent methods of delivering the placenta and measurement of blood loss had to be taught to all staff and students. According to a protocol agreed with the back-up physician, oral methylergometrine and/or IV oxytocin are available in the case of postpartum haemorrhage. Either can be administered during the delivery of the placenta or within one to two hours, depending on when bleeding occurs. Oral methylergometrine is administered when uterine atony occurs but is responding to care such as fundal massage and bleeding and the midwives consider the bleeding is likely to stop. For immediate heavy blood loss and/or continuous bleeding, IV oxytocin is administered. The midwives in attendance determine severity of blood loss from the nature and speed of blood flow, and the condition of the woman and whether the oral and/ or IV uterotonics should be used. Usually two midwives attend a birth so they can discuss the situation between them, thereby helping their decision-making process.
Haemoglobin (Hb) is checked if the woman has had a blood loss of more than 1000ml (as per the protocol with the backup physician) or at the midwives' discretion if they consider the woman to be clinically anaemic. If Hb is lower than 10g/dl the physician will prescribe oral iron on the day of discharge (fifth day). IV iron can be also administered immediately after birth and in the postpartum period if a PPH has occurred. According to the protocol, if the woman has a blood loss of 1000ml or more, IV iron should be administered within one to two hours of the birth and every day up to the fourth day postpartum.
METHOD
This was a retrospective cohort study with data extracted from the birth records of the 512 women who gave birth at one Japanese maternity home between January 2007 and February 2010. Inclusion criteria were: low risk women with no major problem during pregnancy, singleton pregnancies, cephalic presentations and spontaneous onsets of labour between 37 weeks and 42 weeks. No medicine or medical procedures were used during the first or the second stages of labour for these 512 women. If either was required the woman was transferred to the back-up physician or the back-up institution and these women were excluded from this study.
The primary outcome of the study was blood loss volume during and following birth. The definition of blood loss has been described earlier. Blood loss was measured at the end of the third stage, and at one and two hours later. These measurements were added together to provide the total blood loss. Blood loss was measured and documented by midwives as a routine practice in the way described earlier. This documentation was then retrospectively analysed. Secondary outcomes were: requirement for either oral or IV therapeutic uterotonic treatment, requirement for IV iron therapy, weight of baby, length of the third stage of labour, length of labour, parity, age, mother's body mass index (BMI, calculated as follows: weight (kg) ÷ {height (m) x height (m)}), condition of placenta, perineal lacerations, postpartum Hb levels up to day four and at week two when reported. Changes in Hb levels, from the last antenatal Hb measurement to Hb levels at day four postpartum, were calculated.
Data analysis
Blood loss was divided into five groups by 500ml increments and then combined into four quartiles for the purpose of statistical analysis. Analysis included ANOVA, student t-tests, and Pearson's r, and all data were analysed using SPSS v12. A p value of <0.05 was considered to be statistically significant.
Ethical consideration
This study was approved by the Institutional Review Board of Tenshi College, Japan.
FINDINGS Demographics
Demographics of the study participants are shown in Table 1 . These include mean age and parity of women, gestational ages, newborn birth weights, Apgar scores, lengths of the third stage and lengths of labour and delivery. The women who had been accepted to have their baby in the maternity home therefore were at low risk; however, there were three newborn and two maternal transfers. The mean blood loss at the end of the third stage of labour was 392ml and the mean total blood loss at two hours following birth was 608ml ( Table 2 ). The sample consisted of almost 80% multiparas (n=406), but there was no significant difference in total blood loss between primiparas and multiparas (t=-1.30, p=0.19). Parity was not significantly associated with total blood loss (F=0.59, p=0.67).
Blood loss
The placenta and the membranes were intact in 98.4% and in 92% of the births, respectively, and 45.1 % of the perineums were intact (Table 3 ). Among women who had perineal lacerations (54.9%), 79.4% (n=223) had first degree and 20.6% (n=58) had second degree lacerations. There were no third or fourth degree lacerations. The total blood loss was not associated with whether or not the placenta was intact (t=0.95, p=0.34), the membranes were intact (t=0.98, p=0.33), or the perineum was intact (t=0.39, p=0.69). (Table 3) The total blood loss was positively correlated with the weight of the placenta (r=0.29, p=0.00), the baby's weight (r=0.20, p=0.00) and the woman's BMI (r=0.17, p=0.01), and negatively correlated with the woman's age (r=-0.12, p=0.01). The woman's BMI was also positively correlated with blood loss at one hour and two hours (r=0.12, p=0.01, and r=0.16, p=0.00, respectively). The length of the third stage did not correlate with either blood loss at the end of third stage or total blood loss (r=0.08, p= 0.07, and r=0.04, p=0.39, respectively). (Table 4) Total blood loss volumes and uterotonic administration frequencies are shown in Table 5 . The majority of women in the cohort lost between 500ml and 999ml of blood and accounted for 84% of the total sample. Two of the mothers with excessive blood loss were transferred to hospital for management of their severe postpartum haemorrhages. The mean BMI of the women was compared over the four blood loss groups, 0-499ml, 500-999ml, 1000-1499ml and ≥1500ml and were 20.1, 20.7, 20.5 and 20.7 respectively, with no significant differences among the groups (F=2.49, p=0.06).
Therapeutic use of uterotonics
Of the women who had a blood loss of less than 1000ml, one third (32.1%) were given oral therapeutic uterotonics (Table 5 ) and 3.1% were given IV uterotonics. The majority of women who had blood loss of 1000-1499ml were given oral therapeutic uterotonics with 25.9% being given IV. In contrast, almost all the women who lost more than 1500ml of blood needed oral and/or IV therapeutic uterotonics. Overall, 7.8% of the cohort needed IV uterotonics. Haemoglobin levels in the postpartum period The numbers of women who had an Hb taken and/or were treated for anaemia are provided in Table 6 . IV iron was administered to 5.6% of the women who had had a blood loss of less than 1000ml, and to 75.9% of the women who had had a blood loss of 1000-1499ml. All of the women with a blood loss of more than 1500ml received iron therapy.
The mean Hb level at four days postpartum for women with a blood loss ≥1500ml was 8.3 g/dl (SD=1.0). This was significantly lower than the 9.8g/dl (SD=1.2) found for women who had a blood loss of 1000-1499ml and the 9.6g/dl (SD=0.9) for women with a loss of 500-999ml (F=27.92, p<.001).
The decreases in Hb level between the last antenatal check and at four days postpartum were compared among the three groups of blood loss (Table 6 ). The mean decrease in Hb levels was significantly higher for women who had a blood loss of ≥1500ml than the mean decrease in the women whose blood loss was 1000-1499ml or 500-999ml (F=11.90, p<.001). There was no significant difference in the decrease of mean hemoglobin levels with a blood loss of 500-999ml compared to a blood loss of 1000-1499ml (Table 6 ).
Regardless of the woman's blood loss, by two weeks postpartum Hb levels were almost 11g with or without iron therapy and there were no statistically significant differences among the groups (F=0.66, p=0.54).
Other events affecting mothers and newborns
Three newborn transfers occurred. Two were due to respiratory problems and one was due to a persistent fever. Phototherapy for jaundice was given to 2.0% (n=10) babies. At two weeks postpartum 93.8% of mothers were breastfeeding completely, 2.1% were breastfeeding partially and 2 (0.4%) women were using formula only. Breastfeeding status was not associated with total blood loss (t=1.52, p=0.13).
DISCUSSION
In our study, the women were healthy and no interventions took place throughout the first, second and third stages of labour and birth. We found that approximately half (52%) of our cohort had a total blood loss of less than 500ml and a further 32% had a blood loss of 500-999ml. Therefore, the majority (84%) of this normal low risk cohort had a total blood loss, at two hours following the birth, of less than 1000ml, with an average of 608ml. Parity and first and second degree lacerations did not affect the blood loss volume. Furthermore, there were only two obese (BMI>30) women in our study.
Therapeutic intravenous uterotonics were administered to 3.1% of women when blood loss was <1000ml but given to 83.3% when the loss exceeded 1500ml.
Blood loss in our study appears to be higher than what has traditionally been considered normal but adverse effects were not apparent unless the women had a blood loss of ≥1500ml, at which time the mean Hb level was significantly lower when compared to other blood loss volumes. In addition, for this group, the decrease in Hb levels in the early postpartum stage when compared to the last antenatal Hb level was also significantly larger.
Our findings are consistent with other studies that suggest women can tolerate a blood loss of up to 1000ml without this having any long term impact on their health (Blackburn, 2008; Bloomfield & Gordon, 1990; Frye, 2004; Gyte, 1992) .
The results of our study differ from those reported by the studies reviewed by Dixon et al. (2011) . In this review Thilaganathan et al. (1993) , Dixon et al. (2009) and Bais, Eskes, Pel, Bonsel and Bleker (2004) reported mean blood losses of 200ml, 213.6ml and 361ml, respectively. The wide variation may be due to timing of blood loss measurement in each study.
A Swedish randomised controlled trial (Jangsten et al., 2011) , comparing blood loss dependent on third stage care, compared actively and physiologically managed third stage of labour and found very similar results to our study in the physiologically managed arm. The average blood loss was reported as 680ml and losses of more than 1000ml occurred in 16.8% of the physiologically managed arm.
In our study and in the Swedish study, blood loss was measured for up to two hours following the birth. Whereas, both the Thilaganathan et al. (1993) and the Dixon et al. (2009) studies used estimated loss immediately following the birth. The timing of blood loss measurement was unclear in the study by Bais et al. (2004) .
Despite this difference in timing, if blood loss measures are compared for immediately following the birth, the mean loss for Jangsten et al. (2011) was 395ml and in our study 392ml, both of which are higher than the estimated values of the other studies (Bais et al., 2004; Dixon et al., 2009; Thilaganathan et al., 1993) .
A potential reason for the higher recorded blood loss volume is the method of blood loss measurement. There is evidence that visual estimation results in either over or underestimation of blood loss. When the loss is small, it is more likely to be overestimated and when large it is more likely to be underestimated (Al-Kadri et al., 2014; Dildy, Paine, George, & Velasco, 2004; Newton et al., 1961; Razvi, Chua, Arulkumaran, & Ratnam, 1996; Wallace, 1967) . Brant (1967) found that when the visually estimated loss exceeded 300ml, underestimation was invariable. Razvi et al. (1996) also found that the tendency to underestimate blood loss was greatest when the measured blood loss was greater than 300ml. It is also possible, because traditional teaching may have influenced blood loss measurement with the expectation that the range for normal blood loss is 200-300ml, that this is indeed why most of the estimated losses fell into the 200-300ml range. It is possible that the visually estimated volumes reported by the Thilaganathan et al., (1993) , Dixon et al., (2009) and Bais et al., (2004) studies, were underestimated since they were gauged subjectively and not quantitatively.
Our study and the Swedish study (Jangsten et al., 2011) have sought to measure blood loss with a high degree of accuracy. In the case of the Swedish study, soaked pads with amniotic fluid were removed and a dry sanitary pad was placed under the mother immediately after the birth of the baby, and all sanitary towels and pads were weighed before and after use. In our study, not only was there a protocol for measurement, but there was also consistency of midwifery staff. The method of measurement was consistently taught to all midwifery staff and attending students in the maternity home carrying out the measuring, which has potentially contributed to the accuracy of the measurements.
Despite these similarities there were some differences between our study and that of Jangsten et al. (2011) . In the latter study medical interventions (such as epidural and augmentation) were included in the physiological arm of their study. This could have confounded their results. However, of importance are the similarities between blood loss volumes and rate of occurrence of severe PPH in these two studies.
Therapeutic use of uterotonics, and iron and haemaglobin levels
A third of women in our study had a total blood loss of 500-999ml, did not require therapeutic uterotonics or IV iron replacement and had no clinically signs of anaemia following birth. For women who had a blood loss of 1000-1499ml, one quarter were treated with IV uterotonics and the majority (75.9%) were treated with IV iron, resulting in improved Hb levels postpartum. For those women who had a blood loss volume of more than 1500ml, almost all needed therapeutic uterotonics and IV iron replacement. Despite these treatments, their Hb levels were significantly lower than the levels of the other groups. Furthermore, a loss of ≥1500ml brought about a significantly greater decrease in Hb levels compared to the last antenatal Hb level, suggesting that the level above which immediate intense treatment is required for all women, regardless of their condition antenatally, is this litre and a half level. Lilley et al. (2015) also found that gravimetric measurement of blood loss was correlated with a fall in Hb following PPH where blood loss exceeded 1500ml. They hypothesise that when blood loss exceeds 1500ml, the protective, physiological adaptation of pregnancy is less effective. Our findings are supportive of this hypothesis.
Uterotonics and/or iron were given at the midwives' discretion. Therefore, an individual midwife's perspective can potentially influence treatment given. Our results show that, despite a culture of not using medication unless necessary, the midwives made appropriate assessments and decisions which supported the wellbeing of women.
Physiology of blood loss after pregnancyinduced hypervolemia Cunningham and Williams (2001) argue that when blood loss is measured accurately, a volume in excess of 500ml is not necessarily an abnormal event. Bloomfield and Gordon (1990) agree, suggesting that a fit young woman can cope with a blood loss of up to 1000ml without difficulty because she has increased her circulating blood volume by more than this during pregnancy. During pregnancy a woman increases her blood volume by 30-60% which for an average-sized woman amounts to 1000-2000ml (Cunningham & Williams, 2001 ). Consequently, a woman can tolerate blood loss at delivery approaching the volume of blood she added during pregnancy, without any remarkable decrease in postpartum hematocrit (Cunningham & Williams., 2001) . Therefore, blood loss up to 1000ml may be considered physiological in women who are well nourished and can be considered healthy (World Health Organization, 1996) . Newton et al. (1961) (Cunningham & Williams, 2001 ). In our study, BMI was correlated with blood loss at one hour, two hours and total blood loss. Bloomfield and Gordon (1990) point out that the definition of haemorrhage as a blood loss of 500ml or more does not make allowance for the size of the circulating blood volume of the individual mother.
Some studies in the literature report BMI >30 as a risk factor for excessive blood loss (Fyfe, Thompson, Anderson, Groom, & McCowan, 2012; Schrauwers & Dekker, 2009) . Nevertheless, in our study there was no significant association between mean BMI and excessive blood loss. However, compared to Western populations, the prevalence of obesity is much lower in Japan, especially among women giving birth at maternity homes. This is demonstrated by the fact that only two women in our study were classified as obese, therefore our finding cannot be generalised to other populations with a higher prevalence of obesity. Further research is necessary to investigate whether a woman's BMI and blood loss are associated physiologically and how we should take this into consideration when we decide how much blood loss constitutes the normal range for an individual woman. This is the first study to evaluate blood loss up to two hours postpartum at a maternity home outside of a hospital setting in Japan. In hospitals, prophylactic uterotonics are routinely used and active management is prevalent, though many variations exist. No other study has been published on blood loss with physiological management of the third stage following physiological birth in Japan to date.
A strength of this study is the consistency of the method of, and the personnel involved in, the measurement of blood loss volume. We found that the total mean blood loss at two hours postpartum was greater than 500ml (therefore, technically defined as a PPH). Our findings provide a baseline for future research aimed at identifying normative blood loss volumes when birth is physiological and the third stage is physiologically managed.
Blood loss of ≥1500ml seemed critical with two maternal transfers and significant falls from the last antenatal Hb levels postpartum. However, almost all women were breastfeeding and recovering well with Hb levels returning to normal levels at two weeks postpartum.
LIMITATIONS
This is a retrospective cohort study which was conducted at one maternity home in Japan. The findings of this study cannot be generalised to other maternity homes. Larger studies are necessary to fully evaluate the normal range of blood loss with physiological management following physiological labour and birth.
Hb levels were not taken from all the women in our cohort. Only women who lost more than 1000ml of blood and those who looked clinically anaemic, even if they had a blood loss of less than 1000ml, had samples taken. Any further study should evaluate all women's Hb levels to judge the effect of blood loss volume.
CONCLUSION
Although these data come only from one maternity home in Japan, they record exact quantities of blood loss at the third stage and up to two hours postpartum, and the results suggest that blood loss volumes of 500-1000ml may be physiologically normal when births are physiological and the third stage is physiologically managed.
Further research is needed to understand the physiology of the blood loss that accompanies childbirth and the physiological reaction to that blood loss, so that we can develop appropriate guidelines for identifying and treating pathological haemorrhage and the administration of therapeutic uterotonics when the birth has been physiological.
